Skip to main content
Apeloa Pharmaceutical Co.,Ltd. logo

Apeloa Pharmaceutical Co.,Ltd. — Investor Relations & Filings

Ticker · 000739 ISIN · CNE000000Q45 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,843 across all filing types
Latest filing 2017-11-26 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 000739

About Apeloa Pharmaceutical Co.,Ltd.

https://www.apeloa.com

Apeloa Pharmaceutical Co., Ltd. focuses on the research, development, manufacturing, and distribution of active pharmaceutical ingredients (APIs), intermediates, and finished dosage forms. The company operates three core business pillars: API production, Contract Development and Manufacturing Organization (CDMO) services, and finished drug products. Its therapeutic focus includes cardiovascular, anti-infective, anti-viral, and oncology treatments. Apeloa utilizes an integrated supply chain to deliver chemical and biological solutions to a global client base. The organization maintains compliance with international quality standards, including certifications from the FDA, EMA, and PMDA. Its CDMO services encompass the full product lifecycle, from process chemistry and analytical development to large-scale commercial manufacturing, supported by specialized technology platforms such as continuous flow chemistry and enzymatic synthesis.

Recent filings

Filing Released Lang Actions
非公开发行股票发行情况报告书暨上市公告书
Capital/Financing Update Classification · 95% confidence The document is titled as a "非公开发行股票发行情况报告书暨上市公告书" which translates to "Non-public Stock Issuance Report and Listing Announcement." It details the issuance of new shares, pricing, subscription, regulatory approvals, and listing arrangements. It includes extensive information about the issuance process, shareholders before and after issuance, and the impact on the company. The document is about a capital raising event through a non-public stock issuance and the subsequent listing of these shares on the Shenzhen Stock Exchange. This fits the definition of a Capital/Financing Update (CAP) as it provides updates on company fundraising and capital structure changes. It is not an Annual Report, Earnings Release, or other report types. The document length is substantial and contains detailed information about the financing event itself, not just an announcement of a report publication. Therefore, the correct classification is CAP with high confidence.
2017-11-26 Chinese
第七届董事会第五次会议决议公告
Board/Management Information Classification · 100% confidence The document is an announcement of resolutions from the company's seventh board of directors meeting held on November 7, 2017. It details changes in the company's board chairman, legal representative, general manager, and adjustments to board committees. The content focuses on management and board changes, including election and resignation of key executives. There are no financial statements, earnings data, or audit information presented. The document is not a full report but an official announcement of board and management changes. Therefore, it fits the category of Board/Management Information (MANG). The document length is 2405 characters, which is consistent with an announcement rather than a full report.
2017-11-07 Chinese
独立董事关于公司董事长和总经理变更的独立意见
Board/Management Information Classification · 100% confidence The document is a statement from independent directors regarding changes in the company's chairman and general manager positions. It references a board meeting and provides an independent opinion on the management changes. There are no financial statements or detailed financial data, nor is it an announcement of voting results or a regulatory filing. The content clearly relates to board/management changes, fitting the Board/Management Information category.
2017-11-07 Chinese
关于收到公司董事、高管辞职的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of company directors and senior management members. It details the resignation of the chairman and the general manager, including effective dates and acknowledgments of their contributions. There is no financial data, no mention of financial results, or regulatory filings beyond the management changes. This fits the definition of 'Board/Management Information' (MANG), which covers announcements of changes in the company's board of directors or senior management.
2017-11-07 Chinese
西南证券股份有限公司关于公司2015年非公开发行股票业绩变化会后事项的核查意见
Capital/Financing Update Classification · 95% confidence The document is a detailed verification opinion from Southwest Securities Co., Ltd. regarding the post-performance changes of a non-public stock issuance by Puluo Pharmaceutical Co., Ltd. It includes audited financial data for 2016 and unaudited data for 2017 Q3, discusses the impact of performance changes on future operations and fundraising projects, and references compliance with regulatory requirements for non-public stock issuance. The document is not a full annual or quarterly report but a verification opinion related to a capital raising event (non-public stock issuance). It contains substantive financial data and analysis related to the capital raising and performance verification. Therefore, it fits best under Capital/Financing Update (CAP) as it relates to the non-public issuance and performance verification for that financing event.
2017-10-31 Chinese
关于公司2016年度及2017年三季度业绩波动不影响非公开发行相关事项的说明
Interim / Quarterly Report Classification · 95% confidence The document is a detailed explanation regarding the company's 2016 annual and 2017 third quarter performance fluctuations and their impact on a non-public stock issuance. It includes audited financial data for 2016 and unaudited data for 2017 Q3, references to regulatory approvals from the China Securities Regulatory Commission, and discusses compliance with issuance regulations. The document contains substantive financial data and analysis, including revenue, profit, and cost figures, as well as management's explanation of performance trends and future outlook. It is not merely an announcement or a certification but a comprehensive report on interim financial performance and related regulatory compliance. Therefore, it fits the definition of an Interim / Quarterly Report (IR). The document length is 4391 characters, slightly below 5000, but the content is substantive and detailed, not just a brief announcement or notice. Hence, the classification is IR with high confidence. 9M 2017
2017-10-31 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.